Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Marpai, Inc.MRAI · Entity 7110 | Director | May 29, 2026 | June 02, 2026 |
| SRAX, Inc.SRAX · Entity 95766 | Director | January 03, 2022 | January 05, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Marpai, Inc.
Report date May 29, 2026 · Filed June 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 267,500 |
Reported balance
After 2026-05-29 transaction · row 1
1 source rowRow 1 · 2026-05-29 · Grant · Acquired 125,000 · Balance 267,500 F1: The restricted stock units were granted pursuant to Marpai Inc.'s 2024 Global Stock Incentive Plan and are deemed fully vested on the issuance date. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units were granted pursuant to Marpai Inc.'s 2024 Global Stock Incentive Plan and are deemed fully vested on the issuance date.
SRAX, Inc.
Report date January 03, 2022 · Filed January 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common Stock Purchase OptionSEC Table II · derivative / convertible security · Conversion / exercise price $4.35 · Expires 2029-01-03 | Direct | 29,533 |
Reported balance
After 2022-01-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-01-03 · Grant · Acquired 29,533 · Balance 29,533 F1: Represents equity grant portion of annual compensation for non-employee director services with such grant valued at $100,000. The options vest quarterly in equal installments on 3/31/22, 6/30/22, 9/30/22, and 12/31/22. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents equity grant portion of annual compensation for non-employee director services with such grant valued at $100,000. The options vest quarterly in equal installments on 3/31/22, 6/30/22, 9/30/22, and 12/31/22.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 29, 2026 Filed Jun 2, 2026 20:56 UTC | Marpai, Inc. MRAI · Entity 7110 | GrantClass A Common Stock | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-064238 · ownership.xml · nonDerivative · entry 1 DiClaudio Colleen · CIK 0001738577 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 267,500 F1 · shares: The restricted stock units were granted pursuant to Marpai Inc.'s 2024 Global Stock Incentive Plan and are deemed fully vested on the issuance date. Read SEC document |
| October 20, 2025 Filed Oct 22, 2025 21:32 UTC | Marpai, Inc. MRAI · Entity 7110 | GrantClass A Common Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-101334 · ownership.xml · nonDerivative · entry 1 DiClaudio Colleen · CIK 0001738577 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,500 F1 · shares: The RSUs are deemed fully vested on the issuance date. Read SEC document |
| May 23, 2024 Filed May 28, 2024 20:01 UTC | Marpai, Inc. MRAI · Entity 7110 | GrantClass A Common Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-065171 · ownership.xml · nonDerivative · entry 1 DiClaudio Colleen · CIK 0001738577 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,000 Read SEC document |
| June 14, 2022 Filed Jun 17, 2022 20:05 UTC | Marpai, Inc. MRAI · Entity 7110 | GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001104659-22-072377 · tm2218660-1_4seq1.xml · derivative · entry 1 DiClaudio Colleen · CIK 0001738577 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Class A Common Stock · 175,000 shares Expires 2032-06-14 F1 · derivative.exercise_date: The option vests monthly over a three-year period, commencing on October 26, 2021. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 18:21 UTC | SRAX, Inc. SRAX · Entity 95766 | GrantClass A Common Stock Purchase Option · Derivative | 29,533 | $0.00 Strike: $4.35 | $0.00 |
DisclosureSEC source: 0001493152-22-000475 · ownership.xml · derivative · entry 1 DiClaudio Colleen · CIK 0001738577 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,533 Underlying: Class A Common Stock · 29,533 shares Expires 2029-01-03 F1 · security: Represents equity grant portion of annual compensation for non-employee director services with such grant valued at $100,000. The options vest quarterly in equal installments on 3/31/22, 6/30/22, 9/30/22, and 12/31/22. Read SEC document |
| April 15, 2020 Filed Apr 17, 2020 20:29 UTC | SRAX, Inc. SRAX · Entity 95766 | GrantClass A Common Stock Purchase Option · Derivative | 9,408 | $0.00 Strike: $1.95 | $0.00 |
DisclosureSEC source: 0001493152-20-006672 · ownership.xml · derivative · entry 1 DiClaudio Colleen · CIK 0001738577 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,408 Underlying: Class A common Stock · 9,408 shares Expires 2027-04-15 F1 · security: Represents 50% of compensatory annual grant for director services of $30,000. The options vest quarterly on 7/15/20, 10/15/20, 1/15/21, and 4/15/21. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 20:34 UTC | SRAX, Inc. SRAX · Entity 95766 | GrantClass A Common Stock Purchase Option · Derivative | 2,813 | $0.00 Strike: $5.49 | $0.00 |
DisclosureSEC source: 0001553350-19-000404 · diclaudio4.xml · derivative · entry 1 DiClaudio Colleen · CIK 0001738577 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,813 Underlying: Class A Common Stock · 2,813 shares Expires 2026-04-15 F1 · security: Represents 50% of compensatory annual grant for director services of $30,000. The options vest quarterly on 7/15/19, 10/15/19, 1/15/20, and 4/15/20. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.